Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease.

JCI insight·2019
Same author

Early E. casseliflavus gut colonization and outcomes of allogeneic hematopoietic cell transplantation.

PloS one·2019
Same author

Publisher Correction: Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion.

Nature·2019
Same author

Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2019
Same author

Validation of Minnesota acute graft-<i>versus</i>-host disease Risk Score.

Haematologica·2019
Same author

Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion.

Nature·2019
Same journal

A guide to CAR T cell therapies: development, current status and future prospects.

Nature reviews. Immunology·2026
Same journal

Macrophages in embryonic development.

Nature reviews. Immunology·2026
Same journal

Glycolytic capacity instructs tumour vasculature and response to immunotherapy.

Nature reviews. Immunology·2026
Same journal

Vaginal NK cells limit epithelial barrier disruption during infection.

Nature reviews. Immunology·2026
Same journal

New insights into progenitor exhausted T cell populations.

Nature reviews. Immunology·2026
Same journal

T cell engagers in autoimmune diseases.

Nature reviews. Immunology·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Isolating Lymphocytes from the Mouse Small Intestinal Immune System
11:28

Isolating Lymphocytes from the Mouse Small Intestinal Immune System

Published on: February 28, 2018

Engineering lymphocyte subsets: tools, trials and tribulations.

Carl H June1, Bruce R Blazar, James L Riley

  • 1Department of Pathology and Laboratory Medicine and Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA. cjune@exchange.upenn.edu

Nature Reviews. Immunology
|October 28, 2009
PubMed
Summary
This summary is machine-generated.

Genetically engineered lymphocyte subsets offer promising cell-based therapies for cancer and immune disorders. This review covers engineering technologies and clinical translation progress for these advanced treatments.

More Related Videos

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

Isolation and Activation of Murine Lymphocytes
08:08

Isolation and Activation of Murine Lymphocytes

Published on: October 30, 2016

Related Experiment Videos

Last Updated: Jun 19, 2026

Isolating Lymphocytes from the Mouse Small Intestinal Immune System
11:28

Isolating Lymphocytes from the Mouse Small Intestinal Immune System

Published on: February 28, 2018

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

Isolation and Activation of Murine Lymphocytes
08:08

Isolation and Activation of Murine Lymphocytes

Published on: October 30, 2016

Area of Science:

  • Immunology
  • Cell Therapy
  • Genetic Engineering

Background:

  • Cell-based therapies utilize lymphocyte subsets for treating diseases like cancer and infections.
  • Genetic engineering of lymphocytes can enhance immune responses and correct deficiencies.

Purpose of the Study:

  • To review lymphocyte subsets modified for therapeutic benefit.
  • To discuss technologies used for lymphocyte engineering.
  • To highlight progress and challenges in clinical translation.

Main Methods:

  • Review of scientific literature on genetically modified lymphocytes.
  • Analysis of current and emerging lymphocyte engineering technologies.
  • Evaluation of clinical trial data and regulatory hurdles.

Main Results:

  • Various lymphocyte subsets are being engineered for therapeutic applications.
  • Diverse technologies exist for modifying lymphocytes, including genetic and non-genetic methods.
  • Significant progress has been made, but clinical translation faces hurdles.

Conclusions:

  • Genetically engineered lymphocytes represent a powerful therapeutic modality.
  • Further technological development and clinical validation are crucial for widespread adoption.
  • These therapies hold significant promise for treating a range of diseases.